.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
Colorcon
Accenture
McKinsey
Federal Trade Commission
Chubb
Farmers Insurance
UBS
Cipla

Generated: January 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: desvenlafaxine succinate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3659-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-10)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3659-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-30)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3659-1990 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-19)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3660-1990 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-19)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3660-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-10)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-3660-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-30)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-4060-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-4060-10)
Actavis Labs FlDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204065ANDAActavis Pharma, Inc.0591-4060-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-4060-30)
Alembic Pharms LtdDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204003ANDAAlembic Pharmaceuticals Limited46708-251-1714 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-251-17)
Alembic Pharms LtdDESVENLAFAXINE SUCCINATEdesvenlafaxine succinateTABLET, EXTENDED RELEASE;ORAL204003ANDAAlembic Pharmaceuticals Limited46708-251-10100 TABLET, EXTENDED RELEASE in 1 CARTON (46708-251-10)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Boehringer Ingelheim
Johnson and Johnson
Merck
Farmers Insurance
Healthtrust
Accenture
UBS
Chubb

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot